“Molecular Docking Study of Gingkgo biloba Compounds as Potential Inhibitors of SARS-CoV-2”, SCRIPTA SCORE Sci Med J., vol. 4, no. 1, pp. 30–43, Sep. 2022, doi: 10.32734/scripta.v4i1.8399.